110 related articles for article (PubMed ID: 8419348)
1. Lipopolysaccharide interaction with S2 subunit of pertussis toxin.
Lei MG; Morrison DC
J Biol Chem; 1993 Jan; 268(2):1488-93. PubMed ID: 8419348
[TBL] [Abstract][Full Text] [Related]
2. Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes.
Lei MG; Morrison DC
Infect Immun; 1993 Apr; 61(4):1359-64. PubMed ID: 7681044
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the lectin-like binding domains in pertussis toxin using synthetic peptide sequences. Identification of a sialic acid binding site in the S2 subunit of the toxin.
Heerze LD; Chong PC; Armstrong GD
J Biol Chem; 1992 Dec; 267(36):25810-5. PubMed ID: 1281475
[TBL] [Abstract][Full Text] [Related]
4. The 70-kilodalton pertussis toxin-binding protein in Jurkat cells.
Armstrong GD; Clark CG; Heerze LD
Infect Immun; 1994 Jun; 62(6):2236-43. PubMed ID: 7514575
[TBL] [Abstract][Full Text] [Related]
5. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.
van't Wout J; Burnette WN; Mar VL; Rozdzinski E; Wright SD; Tuomanen EI
Infect Immun; 1992 Aug; 60(8):3303-8. PubMed ID: 1353482
[TBL] [Abstract][Full Text] [Related]
6. Protein-chemical analysis of pertussis toxin reveals homology between the subunits S2 and S3, between S1 and the A chains of enterotoxins of Vibrio cholerae and Escherichia coli and identifies S2 as the haptoglobin-binding subunit.
Capiau C; Petre J; Van Damme J; Puype M; Vandekerckhove J
FEBS Lett; 1986 Aug; 204(2):336-40. PubMed ID: 3525228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
Schmidt MA; Schmidt W
Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
[TBL] [Abstract][Full Text] [Related]
8. Effects of lipopolysaccharide chemotype structure on binding and inactivation of hen egg lysozyme.
Ohno N; Morrison DC
Eur J Biochem; 1989 Dec; 186(3):621-7. PubMed ID: 2691250
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of pertussis toxin.
Stein PE; Boodhoo A; Armstrong GD; Cockle SA; Klein MH; Read RJ
Structure; 1994 Jan; 2(1):45-57. PubMed ID: 8075982
[TBL] [Abstract][Full Text] [Related]
10. Release of pertussis toxin and its interaction with outer-membrane antigens.
Perera VY; Wardlaw AC; Freer JH
J Gen Microbiol; 1987 Sep; 133(9):2427-35. PubMed ID: 2896225
[TBL] [Abstract][Full Text] [Related]
11. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
Schmidt MA; Raupach B; Szulczynski M; Marzillier J
Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
[TBL] [Abstract][Full Text] [Related]
12. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
[TBL] [Abstract][Full Text] [Related]
13. The subunit S1 is important for pertussis toxin secretion.
Pizza M; Bugnoli M; Manetti R; Covacci A; Rappuoli R
J Biol Chem; 1990 Oct; 265(29):17759-63. PubMed ID: 2211659
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A.
Lei MG; Qureshi N; Morrison DC
Immunol Lett; 1993 Jun; 36(3):245-50. PubMed ID: 7690343
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.
Armstrong GD; Peppler MS
Infect Immun; 1987 May; 55(5):1294-9. PubMed ID: 2437034
[TBL] [Abstract][Full Text] [Related]
16. Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.
Farizo KM; Fiddner S; Cheung AM; Burns DL
Infect Immun; 2002 Mar; 70(3):1193-201. PubMed ID: 11854200
[TBL] [Abstract][Full Text] [Related]
17. The NAD-glycohydrolase activity of the pertussis toxin S1 subunit. Involvement of the catalytic HIS-35 residue.
Antoine R; Locht C
J Biol Chem; 1994 Mar; 269(9):6450-7. PubMed ID: 8119996
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mutant strains producing pertussis toxin cross reacting materials.
Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
[TBL] [Abstract][Full Text] [Related]
19. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells.
Carbonetti NH; Mays RM; Artamonova GV; Plaut RD; Worthington ZE
BMC Microbiol; 2005 Feb; 5():7. PubMed ID: 15691377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
